Evidence Weighed for Suicide/Self-Harm With Obesity Drugs Evidence Weighed for Suicide/Self-Harm With Obesity Drugs

As the EU looks into cases of suicidal thoughts and self-harm associated with the GLP-1 agonists semaglutide, and liraglutide, Novo Nordisk says it is confident of the risk-benefit profile of these agents.Medscape Medical News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Diabetes & Endocrinology News Source Type: news